Medical Net, Inc.
Medical Net, Inc. Fundamental Analysis
Medical Net, Inc. (3645.T) shows weak financial fundamentals with a PE ratio of 71.29, profit margin of 0.61%, and ROE of 2.19%. The company generates $6.5B in annual revenue with strong year-over-year growth of 15.60%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 39.3/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze 3645.T's fundamental strength across five key dimensions:
Efficiency Score
Weak3645.T struggles to generate sufficient returns from assets.
Valuation Score
Moderate3645.T shows balanced valuation metrics.
Growth Score
Moderate3645.T shows steady but slowing expansion.
Financial Health Score
Excellent3645.T maintains a strong and stable balance sheet.
Profitability Score
Weak3645.T struggles to sustain strong margins.
Key Financial Metrics
Is 3645.T Expensive or Cheap?
P/E Ratio
3645.T trades at 71.29 times earnings. This suggests a premium valuation.
PEG Ratio
When adjusting for growth, 3645.T's PEG of 0.13 indicates potential undervaluation.
Price to Book
The market values Medical Net, Inc. at 1.44 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 15.34 times EBITDA. This signals the market has high growth expectations.
How Well Does 3645.T Make Money?
Net Profit Margin
For every $100 in sales, Medical Net, Inc. keeps $0.61 as profit after all expenses.
Operating Margin
Core operations generate 2.24 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $2.19 in profit for every $100 of shareholder equity.
ROA
Medical Net, Inc. generates $0.86 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Medical Net, Inc. generates limited operating cash flow of $0.00, signaling weaker underlying cash strength.
Free Cash Flow
Medical Net, Inc. generates weak or negative free cash flow of $0.00, restricting financial flexibility.
FCF Per Share
Each share generates $0.00 in free cash annually.
FCF Yield
3645.T converts 0.00% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
71.29
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.13
vs 25 benchmark
P/B Ratio
Price to book value ratio
1.44
vs 25 benchmark
P/S Ratio
Price to sales ratio
0.43
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.68
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.57
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.02
vs 25 benchmark
ROA
Return on assets percentage
0.009
vs 25 benchmark
ROCE
Return on capital employed
0.06
vs 25 benchmark
How 3645.T Stacks Against Its Sector Peers
| Metric | 3645.T Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 71.29 | 22.85 | Worse (Expensive) |
| ROE | 2.19% | 996.00% | Weak |
| Net Margin | 0.61% | -61402.00% (disorted) | Weak |
| Debt/Equity | 0.68 | 1.12 | Strong (Low Leverage) |
| Current Ratio | 1.57 | 1.65 | Neutral |
| ROA | 0.86% | -583089.00% (disorted) | Weak |
3645.T outperforms its industry in 1 out of 6 key metrics, but lagging in P/E Ratio.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Medical Net, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
99.90%
Industry Style: Growth, Technology, Streaming
High GrowthEPS CAGR
-182.51%
Industry Style: Growth, Technology, Streaming
DecliningFCF CAGR
-199.22%
Industry Style: Growth, Technology, Streaming
Declining